Integrated Analysis of Glycolytic and Cholesterogenic Genes Identifies Prognostic Metabolic Subgroup of IDH Wild‐Type Glioblastoma
Cancer Medicine · 2026
DOI: 10.1002/cam4.72105 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Zheng Hu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gannan Medical University, Ganzhou, Jiangxi, China. Hauptthemen laut MEDLINE: Glycolysis, Glioblastoma, Isocitrate Dehydrogenase, Brain Neoplasms. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Fujian Province, China.
Abstract (Originalsprache)
Glioblastoma (GBM) is a markedly heterogeneous intracranial tumor characterized by poor prognosis. While distinctive glycolysis and cholesterol synthesis capacities exist within its microenvironment, comprehensive profiling of these metabolic traits remains lacking. Using genomic, transcriptomic, and clinical data from 364 IDH wild‐type GBM cases across The Cancer Genome Atlas (TCGA) and Chinese Glioma Genome Atlas (CGGA) cohorts—supplemented by the Cancer Cell Line Encyclopedia (CCLE) and TCGA cancer cell line data—we performed consensus clustering using glycolytic and cholesterogenic genes. This identified four metabolic subgroups: cholesterogenic, glycolytic, mixed, and quiescent. The mixed subgroup demonstrated the poorest prognosis, whereas the cholesterogenic subgroup exhibited the most favorable outcome. Notably, high CD8+ T cell proportions correlated with worse prognosis in cholesterogenic and quiescent groups, while elevated CD4+ naïve T cells and mast cells associated with poorer outcomes in glycolytic and mixed groups, respectively. The glycolytic subgroup showed lowest expression of mitochondrial pyruvate carriers (MPC1/MPC2), and the mixed subgroup exhibited minimal methylation. Functionally, pharmacological inhibition of MPC with UK‐5099 increased glycolytic flux and lactate production, most prominently in cholesterogenic‐pattern GBM cells, and conditioned media from MPC‐inhibited or glycolytic GBM cells promoted microglial polarization toward an immunosuppressive phenotype, indicating that MPC1/2 may remodel the glycolysis–cholesterol metabolic axis to shape the microglial immune phenotype. Metabolism stratification by glycolytic/cholesterogenic profiles provides novel insights into IDH wild‐type GBM subtypes, supplements existing prognostic frameworks, and may inform the rational design of future metabolism‐directed strategies, although direct therapeutic validation will be required.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gannan Medical University, Ganzhou, Jiangxi, China.
- Department of Neurosurgery, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
- Department of Neurosurgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, China.
- Department of Neurosurgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Neurosurgery, The First Hospital of Quanzhou Affiliated to Fujian Medical University, Quanzhou, Fujian, China.
ORCID-Profile: Zheng Hu, Jiajie Yuan, Renhui Yi
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Fujian Province, China
Zitieren
APA
Hu, Z., Yuan, J., Zeng, Y., Yi, R., & Wang, X. (2026). Integrated Analysis of Glycolytic and Cholesterogenic Genes Identifies Prognostic Metabolic Subgroup of IDH Wild‐Type Glioblastoma. Cancer Medicine. https://doi.org/10.1002/cam4.72105
Vancouver
Hu Z, Yuan J, Zeng Y, Yi R, Wang X. Integrated Analysis of Glycolytic and Cholesterogenic Genes Identifies Prognostic Metabolic Subgroup of IDH Wild‐Type Glioblastoma. Cancer Medicine. 2026. doi:10.1002/cam4.72105
BibTeX
@article{Hu2026,
author = {Hu, Zheng and Yuan, Jiajie and Zeng, Yu and Yi, Renhui and Wang, Xizhao},
title = {Integrated Analysis of Glycolytic and Cholesterogenic Genes Identifies Prognostic Metabolic Subgroup of IDH Wild‐Type Glioblastoma},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.72105}
}
EUVIMED